These sales are routine post-earnings liquidity transactions by two senior executives. The dollar amount is immaterial relative to market cap, and the strong Q2 results and raised guidance provide a bullish fundamental backdrop. No bearish signal from this cluster, monitor for any acceleration in insider selling volume or C-suite departures, but current activity is benign.
ONC drugs
ONC drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 6 $329.80entry
- T+1 · 3mo ago +5.60%α +4.99% · $348.27
- T+5 · 3mo ago +7.95%α +6.73% · $356.01
- T+20 · 3mo ago +9.97%α +9.37% · $362.68
- T+60 · 18d ago +12.29%α +13.96% · $370.33
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two senior insiders at BeOne Medicines (CFO and SVP/General Counsel) sold a combined ~$700K in open-market sales within days of the company's strong Q2 earnings beat and raised guidance. While the dollar amount is trivial relative to the $35.9B market cap (0.002%), the timing, immediately after a bullish earnings report that sent the stock up, suggests routine post-earnings liquidity selling rather than bearish conviction. The cluster is not amplified by the proportionality threshold, and insider sales are weak predictors per academic literature, especially when clustered around common vesting/blackout windows.
Key Financial Metrics
Key Facts
- CFO Aaron Rosenberg sold 1,157 shares at $312.71 for $362K on 2026-08-03
- SVP/General Counsel Henry Lee Chan sold 1,000 shares at $323.69 for $338K on 2026-07-30
- Total insider sales of ~$700K represent 0.002% of ONC's $35.9B market cap
- Sales occurred 1-4 days after Q2 2026 earnings beat (revenue $1.71B, +30% YoY) and raised FY guidance
- Prior 30d insider activity: 4 sells totaling $7.6M, consistent with ongoing liquidity selling pattern
Financial Impact
Insider sales of ~$700K, negligible vs $35.9B market cap
Risk Factors
- Insider sales could accelerate if stock continues to rally, creating overhang
- Any unexpected insider purchases would be a stronger signal than these sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ONC-1785964600353 |
Track record
27 reports on ONC
3 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +12.55% at T+60 after the Aug 5, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $416.54 Now $411.29 −1.26% settles Nov 23
- Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $419.98 Now $411.29 −2.07% settles Nov 18
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $417.33 to $411.29 Now $411.29 −1.45% ▼ −1.45% +0.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $406.96 to $416.54 Now $411.29 +1.06% ▲ +2.35% −0.24% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $387.25 to $415.96 Now $411.29 +6.21% ▲ +7.41% +4.12% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $377.78 to $419.98 Now $411.29 +8.87% ▲ +11.17% +12.08% vs SPY
- Oct 2, 20266w ago Insider Cluster Bearish 5/10 Entry $361.65 to $350.40 Now $411.29 −13.73% ▲ +3.11% +3.53% vs SPY
- Sep 22, 20267w ago Institutional Cluster Mixed 4/10 Entry $368.08 to $365.27 Now $411.29 +11.74% ▼ −0.76% +0.42% vs SPY
- Sep 10, 20269w ago Insider Cluster Neutral 3/10 Entry $346.51 to $350.84 Now $411.29 +18.69% ▲ +1.25% +1.47% vs SPY
- Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $358.26 to $353.83 Now $411.29 +14.80% ▼ −1.24% −0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers